NYSE:CO Global Cord Blood - CO Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. $2.99 0.00 (0.00%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.99▼$2.9950-Day Range$2.99▼$2.9952-Week Range$2.03▼$5.50VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E Ratio4.67Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Global Cord Blood (NYSE:CO) StockGlobal Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Stock News HeadlinesMarch 28, 2023 | marketwatch.comCord Blood Banking Market Outlook and Forecast till 2028March 27, 2023 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Research Coverage Started at StockNews.comMarch 29, 2023 | The Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 24, 2023 | marketwatch.comCord Blood Stem Cells Market Size, Trends and Forecast 2030March 24, 2023 | marketwatch.comCord Blood Banking Services Market Report | Global Forecast From 2023 To 2030March 23, 2023 | marketwatch.comCord Blood Banking Service Market Size 2023 Global Industry Growth Analysis by Segmentation and Forecast till 2026March 22, 2023 | marketwatch.comThe Cord Blood Banking report offers crucial parameter estimations that help forecast how the industry will perform.March 22, 2023 | benzinga.comStem Cell Manufacturing Market to Hit USD 26.6 Bn Valuation by 2033 Due to Rising Demand for Cell Treatments | TMRMarch 29, 2023 | The Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 21, 2023 | marketwatch.com2023-2028 Umbilical Cord Blood (UCB) Stem Cell Market Future and Growth OpportunitiesMarch 20, 2023 | marketwatch.comGlobal Cord Blood Banking Services Market Size by Type (Private Banks, Public Banks, Hybrid Banks) Forecast from 2023 to 2028March 20, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)March 17, 2023 | marketwatch.com2023 Umbilical Cord Blood (UCB) Stem Cell Market: Thorough breakdown for industry leaders Prognosis by 2027March 15, 2023 | marketwatch.comStem Cell Umbilical Cord Blood Market Statistics [2023-2028]: Emerging Trends and Future Growth ScenarioMarch 15, 2023 | marketwatch.com2023-2028 Umbilical Cord Blood Banking Market Predictions and Growth Opportunities | Latest Research ReportMarch 15, 2023 | marketwatch.comStem Cell Umbilical Cord Blood Market Share and Forecast till 2028March 14, 2023 | marketwatch.comCord Blood Banking Service Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027March 11, 2023 | marketwatch.comGlobal Cord Blood Banking Market Growth, Size and Manufacturers Analysis Research Report and Forecast 2023-2030 By VMReportsMarch 10, 2023 | marketwatch.comUmbilical Cord Blood Banking Market Application, Product, Sales and Forecast 2023-2028March 10, 2023 | marketwatch.comThe Growth of Stem Cell Umbilical Cord Blood Market 2023 and Its Impact on the Global Industry till 2027March 9, 2023 | marketwatch.comCord Blood Stem Cells Market 2023 : New Recent Developments, Trade Regulations, Import Export AnalysisMarch 8, 2023 | marketwatch.comCord Blood Banking Market New Updates Drivers, Challenges and Competitive Strategic Window for Opportunities till 2028March 4, 2023 | marketwatch.comCord Blood Stem Cells Market Statistics | Forecast 2023-2028March 3, 2023 | marketwatch.comCord Blood Stem Cells Market: Global Insights and Industry Outlook 2023-2028March 2, 2023 | marketwatch.comCord Blood Banking Services Market Size PESTAL Analysis 2023 | Latest Survey Report by Absolute Reports till 2025March 2, 2023 | marketwatch.comCord Blood Banking Services Market and its Economic Impact on Industry upto 2028February 27, 2023 | marketwatch.comCord Blood Banking Market New Innovations and Future Expansion 2023-2028See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Company Calendar Last Earnings6/26/2018Today3/29/2023Fiscal Year End3/31/2023Next Earnings (Estimated)4/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio4.67 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$196.12 million Price / SalesN/A Cash Flow$0.71 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.47Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable Beta-0.04 Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey Competitors111NASDAQ:YIAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlopexxNASDAQ:ALPXAlpha Tau MedicalNASDAQ:DRTSWView All CompetitorsInstitutional OwnershipMoneta Group Investment Advisors LLCBought 26,067,412 shares on 2/15/2023Ownership: 0.000%View All Institutional Transactions CO Stock - Frequently Asked Questions How have CO shares performed in 2023? Global Cord Blood's stock was trading at $2.9876 at the beginning of 2023. Since then, CO shares have increased by 0.0% and is now trading at $2.9876. View the best growth stocks for 2023 here. When is Global Cord Blood's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 3rd 2023. View our CO earnings forecast. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) posted its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." Who are Global Cord Blood's major shareholders? Global Cord Blood's stock is owned by a variety of institutional and retail investors. Top institutional investors include Moneta Group Investment Advisors LLC (0.00%), Susquehanna International Group LLP (0.00%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $2.99. How many employees does Global Cord Blood have? The company employs 1,202 workers across the globe. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181. This page (NYSE:CO) was last updated on 3/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.